These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 7517044)

  • 1. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
    Bergelson JM; Chan M; Solomon KR; St John NF; Lin H; Finberg RW
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6245-8. PubMed ID: 7517044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.
    Clarkson NA; Kaufman R; Lublin DM; Ward T; Pipkin PA; Minor PD; Evans DJ; Almond JW
    J Virol; 1995 Sep; 69(9):5497-501. PubMed ID: 7543583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
    Karnauchow TM; Tolson DL; Harrison BA; Altman E; Lublin DM; Dimock K
    J Virol; 1996 Aug; 70(8):5143-52. PubMed ID: 8764022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.
    Powell RM; Schmitt V; Ward T; Goodfellow I; Evans DJ; Almond JW
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1707-13. PubMed ID: 9680134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
    Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
    Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
    Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1.
    Shenoy-Scaria AM; Kwong J; Fujita T; Olszowy MW; Shaw AS; Lublin DM
    J Immunol; 1992 Dec; 149(11):3535-41. PubMed ID: 1385527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decay-accelerating factor protects human trophoblast from complement-mediated attack.
    Cunningham DS; Tichenor JR
    Clin Immunol Immunopathol; 1995 Feb; 74(2):156-61. PubMed ID: 7530176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
    Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
    J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-surface expression of an amino-terminal fragment of apolipoprotein B increases lipoprotein lipase binding to cells.
    Pang L; Sivaram P; Goldberg IJ
    J Biol Chem; 1996 Aug; 271(32):19518-23. PubMed ID: 8702644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.
    Spiller OB; Goodfellow IG; Evans DJ; Almond JW; Morgan BP
    J Infect Dis; 2000 Jan; 181(1):340-3. PubMed ID: 10608785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.
    He Y; Lin F; Chipman PR; Bator CM; Baker TS; Shoham M; Kuhn RJ; Medof ME; Rossmann MG
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10325-9. PubMed ID: 12119400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of decay accelerating factor CD55.
    Nicholson-Weller A; Wang CE
    J Lab Clin Med; 1994 Apr; 123(4):485-91. PubMed ID: 7511675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG; Mold C; Atkinson JP; Medof ME
    J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.
    Fletcher A; Bryant JA; Gardner B; Judson PA; Spring FA; Parsons SF; Mallinson G; Anstee DJ
    Immunology; 1992 Mar; 75(3):507-12. PubMed ID: 1374058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.
    Saifuddin M; Parker CJ; Peeples ME; Gorny MK; Zolla-Pazner S; Ghassemi M; Rooney IA; Atkinson JP; Spear GT
    J Exp Med; 1995 Aug; 182(2):501-9. PubMed ID: 7543140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.